India Infectious Disease Diagnostics Market (2025-2030)
The India Infectious Disease Diagnostics Market was valued at $714.9 Million in 2025 and projected to reach to $1353.7 Million by 2030, representing a compound annual growth rate of 13.6%. India's infectious disease diagnostics market is poised for exceptional growth over the next five years, driven by a convergence of demographic, epidemiological, and infrastructural factors.
India Infectious Disease Diagnostics Market Trends and Insights
- This represents a compound annual growth rate (CAGR) of 13.6%, significantly outpacing global market growth of 9.7%.
- India's rapid urbanization, rising disease burden, and increasing healthcare infrastructure investment are driving demand for advanced diagnostic solutions across the country. The Indian market benefits from a large patient population, growing awareness of early disease detection, and government initiatives promoting diagnostic accessibility.
- India's expanding middle class and improving healthcare spending are accelerating adoption of molecular and point-of-care testing technologies.
- By 2030, India is expected to consolidate its position as a key growth engine within the Asia Pacific region, with diagnostic capabilities increasingly integrated into primary and secondary healthcare facilities nationwide. India's infectious disease diagnostics sector is characterized by rising competition among domestic and international players, coupled with regulatory improvements that streamline product approvals.
- The market's trajectory reflects India's commitment to strengthening disease surveillance and diagnostic capacity across both urban and rural settings..
Key Market Statistics
- CAGR (2025-2030) 13.6% CAGR
- Market Size, 2025 ~USD 714.9 Million
- Forecast, 2030 ~USD 1353.7 Million
- Country India
India Infectious Disease Diagnostics Market Overview
Fastest Growing Market Globally :
India's infectious disease diagnostics market is expanding at 13.6% CAGR, significantly outpacing the global growth rate of 9.7%, making it one of the most attractive markets for diagnostics innovation and investment.
Rapid Market Expansion :
The market is projected to nearly double from USD 714.9 million in 2025 to USD 1,353.7 million by 2030, driven by increasing disease prevalence, urbanization, and government healthcare initiatives across India.
Rising Healthcare Infrastructure Investment :
India's commitment to expanding diagnostic capabilities through government programs like Ayushman Bharat and increased private sector participation is creating substantial opportunities for infectious disease diagnostic solutions.
High Disease Burden Driving Demand :
India's significant burden of infectious diseases including tuberculosis, dengue, malaria, and COVID-19 variants continues to fuel demand for advanced diagnostic technologies and point-of-care testing solutions.
India Infectious Disease Diagnostics Market Dynamics
- Rapid urbanization, coupled with rising disease prevalence and increased healthcare spending, creates a compelling environment for diagnostic innovation.
- Government initiatives promoting preventive healthcare and diagnostic accessibility are accelerating market penetration across urban and semi-urban regions. The market's 13.6% CAGR reflects strong demand for molecular diagnostics, immunoassays, and point-of-care testing solutions.
- Increasing awareness among healthcare providers and patients, combined with improving reimbursement policies, will further accelerate adoption.
- Strategic investments by both domestic and international players in manufacturing and distribution networks are expected to enhance market accessibility and drive sustained growth through 2030..
Related Ecosystem
In Vitro Diagnostics
Medical Devices
Key Takeaways
- India's infectious disease diagnostics market is projected to nearly double from USD 714.9M (2025) to USD 1,353.7M (2030), driven by 13.6% CAGR growth.
- India's large population, rising disease prevalence, and government healthcare initiatives are accelerating demand for diagnostic testing across urban and rural regions.
- Molecular and point-of-care testing technologies are gaining traction in India due to improved affordability and accessibility in primary healthcare settings.
- India's diagnostic market is increasingly competitive, with both domestic manufacturers and international players expanding their presence to capture growing demand.
Infectious Disease Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | MOSQUITO-BORNE DISEASES (Disease Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 9.7% from 2025 to 2030 |
| Largest Segment | LABORATORY TESTING (Type Of Testing) |
| Market Size Base Year (Billions) | ~USD 26.56 (2025) |
| Revenue Forecast (Billions) | ~USD 42.2 (2030) |
| Segments Covered | Product & Service, Type Of Testing, Sample Type, Disease Type, Type, Technology |
India Infectious Disease Diagnostics Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product & Service
- Instruments
- Reagents, Kits, And Consumables
- Software & Services
By Type Of Testing
- Laboratory Testing
- Poc Testing
By Sample Type
- Blood, Serum, And Plasma
- Other Sample Types
- Urine
By Disease Type
- Chlamydia Trachomatis
- Hepatitis
- Hiv
- Hospital-Acquired Infections
- Hpv
- Influenza
- Mosquito-Borne Diseases
- Neisseria Gonorrhea
- Other Infectious Diseases
- Syphilis
- Tuberculosis
By Type
- Hepatitis B
- Hepatitis C
- Other Hepatitis Diseases
By Technology
- Clinical Microbiology
- Dna Microarray
- Dna Sequencing & Next-Generation Sequencing
- Immunodiagnostics
- Isothermal Nucleic Acid Amplification Technology
- Other Technologies
- Polymerase Chain Reaction
Target Audience
- Diagnostic Device Manufacturers : Manufacturers need India-specific market data to assess market size, growth potential, and competitive landscape for launching or expanding infectious disease diagnostic products in this high-growth market.
- Healthcare Investment Firms : Investment professionals require detailed India market forecasts and growth drivers to evaluate investment opportunities, identify promising companies, and make informed capital allocation decisions in the diagnostics sector.
- Hospital & Laboratory Networks : Healthcare facility operators need market insights to understand diagnostic demand trends, procurement opportunities, and technology adoption patterns to optimize service offerings and capital investments.
- Government & Policy Makers : Healthcare policymakers and government agencies require market intelligence to design effective diagnostic programs, allocate healthcare budgets, and develop strategies aligned with India's disease burden and infrastructure needs.
- Pharmaceutical & Biotech Companies : Pharma and biotech firms need India market data to identify diagnostic partnerships, understand testing trends for drug development, and align commercial strategies with market growth opportunities.
Key Companies in the India Infectious Disease Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation data for India (USD 714.9M in 2025) with verified 13.6% CAGR projections through 2030, enabling accurate financial forecasting and investment decision-making for market entry or expansion.
- Competitive Positioning Intelligence : Understand India's market dynamics relative to global trends (9.7% CAGR), identifying competitive advantages and market gaps specific to the Indian infectious disease diagnostics landscape for strategic positioning.
- Growth Driver Identification : Access detailed insights into India-specific growth catalysts including urbanization patterns, disease burden trends, healthcare infrastructure investments, and government initiatives shaping market demand and opportunities.
- Investment & Expansion Strategy : Leverage comprehensive India market data to develop targeted go-to-market strategies, identify high-potential segments, and allocate resources effectively for manufacturing, distribution, and partnership development.
- Regulatory & Market Access Insights : Gain understanding of India's healthcare ecosystem, reimbursement policies, regulatory requirements, and infrastructure gaps critical for successful product launches and sustainable market penetration strategies.
Frequently asked questions
What is the current size of India's infectious disease diagnostics market?
India's infectious disease diagnostics market was valued at USD 714.9 million in 2025 and is expected to grow to USD 1,353.7 million by 2030.
What is the projected growth rate for India's infectious disease diagnostics market?
India's infectious disease diagnostics market is projected to grow at a compound annual growth rate (CAGR) of 13.6% from 2025 to 2030.
What factors are driving growth in India's infectious disease diagnostics market?
Key growth drivers in India include rising disease burden, government healthcare initiatives, expanding middle-class population, improved healthcare infrastructure, and increasing adoption of molecular and point-of-care testing technologies.
Which diagnostic technologies are gaining adoption in India?
Molecular diagnostics and point-of-care testing solutions are experiencing rapid adoption in India due to their improved affordability, accessibility, and integration into primary healthcare facilities.
How does India's market growth compare to global trends?
India's infectious disease diagnostics market is growing at 13.6% CAGR, significantly outpacing the global market growth rate of 9.7%, positioning India as a key growth driver in the Asia Pacific region.
RESEARCH METHODOLOGY
The study analyzes key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. The objectives include tracking company developments such as acquisitions, product/service launches & approvals, expansions, agreements, and partnerships of the leading players. These parameters were evaluated on various parameters within the broad business & product strategy categories. Top-down and bottom-up approaches were used to estimate the market size. The market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify & collect information for this study.
Primary Research
In the primary research process, various sources from both the supply & demand sides were interviewed to obtain qualitative & quantitative information for this report. Primary sources included experts from the core & related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain & verify critical qualitative & quantitative information and assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
| COMPANY NAME | DESIGNATION |
|---|---|
| Abbott (US) | Sales Manager |
| Becton, Dickinson and Company (US) | Product Manager |
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the infectious disease diagnostics market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the infectious disease diagnostics market have been determined through primary & secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Infectious disease diagnostics can be defined as various techniques and products (including kits, assays, tests, reagents, and analyzers) used by healthcare professionals to detect and diagnose disease-causing pathogens in human samples such as serum, blood, urine, throat swabs, and stool, among others.
Stakeholders
- Manufacturers & distributors of infectious disease diagnostics
- IVD companies
- Hospitals & clinics
- Academic research institutes
- Diagnostic laboratories
- Blood banks
- Home health agencies
- Market research & consulting firms
- Government associations
- Venture capitalists & investors
Report Objectives
- To define, describe, segment, and forecast the global infectious disease diagnostics market by product & service, type of testing, sample type, disease type, technology, clinical application, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall infectious disease diagnostics market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
- To benchmark players within the infectious disease diagnostics market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
Get the Full Infectious Disease Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Infectious Disease Diagnostics Market.
- US Infectious Disease Diagnostics Market
- Canada Infectious Disease Diagnostics Market
- Germany Infectious Disease Diagnostics Market
- UK Infectious Disease Diagnostics Market
- France Infectious Disease Diagnostics Market
- Italy Infectious Disease Diagnostics Market
- Spain Infectious Disease Diagnostics Market
- China Infectious Disease Diagnostics Market
- Japan Infectious Disease Diagnostics Market
- Brazil Infectious Disease Diagnostics Market
- Mexico Infectious Disease Diagnostics Market
- United Arab Emirates Infectious Disease Diagnostics Market
- Rest Of Europe Infectious Disease Diagnostics Market
- Rest Of Asia Pacific Infectious Disease Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report